S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.55
+1.87
+11.21%
TNON · Tenon Medical, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$2.51
+0.00
(+0.00%)
● At close: October 21 at 4:00:00 PM EDT
$2.50
-0.01
(-0.40%)
Pre-Market:
5:02:10 AM EDT
DAY'S RANGE
$2.51
$2.42
$2.57
52-WEEK RANGE
$2.51
$2.40
$50.40
What's happening
- TNON is up 0.00% today, trading at $2.51. — Live quote
- It's trading within 3% of its 52-week low ($2.40). (Finnhub fundamentals)
- Volume today (3,000) is well below its 3-month average of 4,707,660. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-12.35 actual vs. $-8.57 estimated (-44.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 5
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TNON
-92.64%
vs S&P 500
-105.04%
1-YEAR RETURN
TNON
-94.35%
vs S&P 500
-109.72%
6-MONTH RETURN
TNON
-91.34%
3-MONTH RETURN
TNON
-66.48%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-12.35
Est. $-8.57
MISS -44.1%
2026-04-26 (Q1 2026)
$-10.85
Est. $-10.89
BEAT +0.4%
2026-01-26 (Q4 2025)
$-13.30
Est. $-12.85
MISS -3.5%
2025-10-26 (Q3 2025)
$-14.00
Est. $-13.21
MISS -6.0%
Valuation Measures & Ratios
Enterprise Value4$9.4M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.27
Price / Book74.33
EV4 / Revenue1.77
EV4 / EBITDA—
Profit Margin-257.85%
Operating Margin-242.70%
Return on Equity (ROE8)-269.24%
Return on Assets (ROA9)-124.84%
Avg Volume (3M)4,707,660
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.8M | — | $338.9M | $7.6M | — |
| P/E | -0.28 | — | -26.26 | -0.56 | — |
| Price/Sales | 0.86 | — | 101.17 | 2.46 | — |
| Price/Book | -2.16 | — | 70.64 | 1.13 | — |
| EV/Revenue | 0.47 | — | 100.14 | -0.09 | — |
| ROE | 782.21% | — | -269.03% | -199.54% | — |
| ROA | -137.41% | — | -124.52% | -120.52% | — |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short60,789
Change from Prior Settlement-88.73%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 126.8% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-09-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -257.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -94.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TNON
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.4M | $1.2M | $564.0K | $726.0K | $887.0K | $901.0K | $719.0K |
| Gross profit | $814.0K | $945.0K | $773.0K | $245.0K | $323.0K | $418.0K | $470.0K | $470.0K |
| Operating income | -$3.4M | -$3.3M | -$3.4M | -$2.9M | -$3.7M | -$3.2M | -$3.9M | -$3.5M |
| Net income | -$4.0M | -$3.5M | -$3.3M | -$2.8M | -$3.6M | -$3.2M | -$3.8M | -$3.6M |
| EPS (diluted) | $-12.35 | $0.31 | $-0.40 | $-12.76 | $1.01 | $-3.63 | $-8.16 | $-10.02 |
| EPS (basic) | $-12.35 | $-0.31 | $-0.40 | $-12.76 | $-1.01 | $-3.63 | $-8.16 | $-10.02 |
| Operating margin | -$262 | -$238 | -$289 | -$507 | -$506 | -$362 | -$430 | -$488 |
| Net margin | -$317 | -$252 | -$285 | -$491 | -$498 | -$359 | -$425 | -$497 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $9.9M | $12.8M | $10.8M | $10.4M | $11.1M | $13.4M | $9.8M | $13.0M |
| Total liabilities | $11.7M | $10.9M | $5.7M | $5.6M | $4.4M | $4.0M | $3.9M | $4.8M |
| Stockholders' equity | -$1.7M | $1.9M | $5.0M | $4.8M | $6.7M | $9.4M | $6.0M | $8.2M |
| Total current assets | $4.8M | $7.6M | $6.8M | $6.5M | $9.9M | $12.0M | $8.2M | $11.2M |
| Total current liabilities | $8.3M | $7.4M | $3.2M | $3.0M | $2.6M | $2.2M | $1.9M | $3.2M |
| Cash & equivalents | $1.7M | $4.6M | $3.8M | $3.4M | $7.8M | $10.3M | $6.5M | $9.2M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $1.9M | $2.0M | $1.7M | $1.3M | $770.0K | $886.0K | $863.0K | $876.0K |
| Inventory | $783.0K | $806.0K | $1.1M | $1.4M | $688.0K | $607.0K | $606.0K | $607.0K |
| Property, plant & equipment | $771.0K | $901.0K | $918.0K | $663.0K | $842.0K | $698.0K | $752.0K | $906.0K |
| Goodwill | $2.4M | $2.4M | $2.4M | $2.4M | — | — | — | — |
| Intangible assets | $455.0K | $470.0K | $485.0K | $500.0K | — | — | — | — |
| Accounts payable | $628.0K | $646.0K | $845.0K | $625.0K | $894.0K | $496.0K | $369.0K | $1.1M |
| Accrued liabilities | $2.0M | $1.8M | $1.6M | $1.5M | $1.1M | $911.0K | $910.0K | $908.0K |
| Common stock & paid-in capital | — | $11.0K | $11.0K | $9.0K | $8.0K | $8.0K | $3.0K | $3.0K |
| Retained earnings | -$88.8M | -$84.8M | -$81.3M | -$78.5M | -$75.1M | -$72.4M | -$68.7M | -$65.7M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.8M | -$3.0M | -$2.2M | -$3.8M | -$2.2M | -$2.5M | -$2.8M | -$2.3M |
| Investing cash flow | -$172.0K | -$56.0K | -$192.0K | -$639.0K | -$192.0K | — | $37.0K | -$104.0K |
| Financing cash flow | $0 | $3.9M | $2.7M | $59.0K | -$59.0K | $6.3M | $113.0K | $9.6M |
| Free cash flow | -$2.9M | -$3.0M | -$2.4M | -$3.7M | -$2.4M | — | -$2.7M | -$2.4M |
| Capital expenditures | $172.0K | $56.0K | $192.0K | -$111.0K | $192.0K | — | -$37.0K | $104.0K |
| Depreciation & amortization | — | — | — | — | — | — | — | $102.0K |
| Share-based compensation | $412.0K | $331.0K | $344.0K | $58.0K | $417.0K | $872.0K | $883.0K | $910.0K |
| Change in accounts receivable | -$27.0K | $282.0K | $403.0K | $541.0K | -$116.0K | $23.0K | -$18.0K | $197.0K |
| Change in inventory | -$280.0K | -$248.0K | -$167.0K | $484.0K | $81.0K | -$11.0K | -$1.0K | -$2.0K |
| Change in accounts payable | -$18.0K | -$199.0K | $220.0K | -$259.0K | $398.0K | $127.0K | -$724.0K | -$18.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $3.9M | $3.3M | $2.9M | $691.0K | $160.0K |
| Gross profit | $2.4M | $1.7M | $1.2M | -$641.0K | $105.0K |
| Operating income | -$12.8M | -$13.8M | -$15.7M | -$18.7M | -$6.5M |
| Net income | -$12.6M | -$13.7M | -$15.6M | -$18.9M | -$7.0M |
| EPS (diluted) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 |
| EPS (basic) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 |
| Operating margin | -$324 | -$420 | -$537 | -$2.7K | -$4.0K |
| Net margin | -$318 | -$417 | -$532 | -$2.7K | -$4.4K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $10.8M | $9.8M | $6.3M | $11.1M | $9.3M |
| Total liabilities | $5.7M | $3.9M | $5.6M | $4.8M | $16.2M |
| Stockholders' equity | $5.0M | $6.0M | $778.0K | $6.3M | -$20.6M |
| Total current assets | $6.8M | $8.2M | $3.9M | $9.3M | $7.7M |
| Total current liabilities | $3.2M | $1.9M | $3.1M | $2.5M | $15.3M |
| Cash & equivalents | $3.8M | $6.5M | $2.4M | $2.1M | $2.9M |
| Marketable securities (current) | — | — | — | $6.4M | $4.4M |
| Accounts receivable | $1.7M | $863.0K | $518.0K | $228.0K | $76.0K |
| Inventory | $1.1M | $606.0K | $554.0K | $415.0K | $188.0K |
| Property, plant & equipment | $918.0K | $752.0K | $961.0K | $793.0K | $101.0K |
| Goodwill | $2.4M | — | — | — | — |
| Intangible assets | $485.0K | — | — | — | — |
| Accounts payable | $845.0K | $369.0K | $433.0K | $550.0K | $478.0K |
| Accrued liabilities | $1.6M | $910.0K | $808.0K | $717.0K | $1.1M |
| Common stock & paid-in capital | $11.0K | $3.0K | $3.0K | $1.0K | $1.0K |
| Retained earnings | -$81.3M | -$68.7M | -$55.1M | -$39.5M | -$20.6M |
| Accumulated other comprehensive income (loss) | — | — | -$46.0K | -$100.0K | -$91.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$10.7M | -$9.9M | -$12.2M | -$12.0M | -$4.3M |
| Investing cash flow | -$1.0M | -$186.0K | $6.1M | -$2.9M | -$4.5M |
| Financing cash flow | $9.0M | $14.1M | $6.3M | $14.1M | $11.5M |
| Free cash flow | -$11.0M | -$10.1M | -$12.5M | -$12.9M | -$4.4M |
| Capital expenditures | $273.0K | $186.0K | $361.0K | $847.0K | $102.0K |
| Depreciation & amortization | — | — | $199.0K | $78.0K | — |
| Share-based compensation | $1.7M | $3.8M | $4.1M | $2.9M | $377.0K |
| Change in accounts receivable | $851.0K | $386.0K | $290.0K | $152.0K | $61.0K |
| Change in inventory | $387.0K | $52.0K | $139.0K | $227.0K | $145.0K |
| Change in accounts payable | $486.0K | -$64.0K | -$117.0K | $72.0K | $444.0K |
| Purchases of investments | — | — | — | $10.1M | $4.4M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TNON as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
No 13F institutional ownership reported for this symbol.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 09:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-16 | 8-K | 2026-09-11 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-09 | 8-K | 2026-09-09 | View on SEC.gov → |
| 2026-09-08 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-09-01 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-31 | 8-K | 2026-08-27 | View on SEC.gov → |
| 2026-08-31 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-24 | 8-K | 2026-08-24 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
Recent news
Headlines about TNON (Tenon Medical, Inc.). Links open the publisher — we don’t host full articles.
-
Tenon Medical To Offer up to $7.18 Million In Common Stock Via ATM Sales
TradingView · 2026-10-16 -
Tenon Medical raises ATM offering capacity to $7.18 million
scanx.trade · 2026-10-16 -
Tenon Medical adds eight new patents issued by USPTO
TipRanks · 2026-10-15 -
Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026
Yahoo Finance · 2026-10-15 -
Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch
Yahoo Finance · 2026-09-30 -
WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338
Yahoo Finance · 2026-09-14 -
WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338
Yahoo Finance · 2026-09-11 -
Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338
Yahoo Finance · 2026-09-11
No headlines in this category right now — try “All”.